Intellectual Property

Goodwin
Intelectual Property (IP)

Goodwin

Accord BioPharma Inc. announced on October 14, 2024 that the FDA had approved IMULDOSA, a biosimilar product to Johnson & Johnson’s STELARA (ustekinumab). IMULDOSA is ...
Goodwin
Intelectual Property (IP)

Goodwin

As previously reported, the District Court for the Northern District of West Virginia, on September 24, 2024 denied Regeneron’s motion for a preliminary injunction to ...
Intelectual Property (IP)

It It The The decision was precedential and authored by Judge Cunningham. Aside from the question about Judge Newman’s treatment by the court, Miller Mendel ...
Patent Term Adjustment Traps to Avoid for Practitioners
Intelectual Property (IP)

Patent Term Adjustment Traps to Avoid for Practitioners

“We, the patent community…should work together to incrementally improve our system and find and fix rules that are not working as intended.” Patent Term Adjustment ...
DLA Piper
Intelectual Property (IP)

DLA Piper

Teva Branded Pharma. Prods. R&D v. Amneal Pharms. The US District Court for the District of New Jersey, in N.Y., LLC, ordered Teva delist five ...
Federal Circuit rejects district court’s overly narrow claim construction in LED patent infringement case
Intelectual Property (IP)

Federal Circuit rejects district court’s overly narrow claim construction in LED patent infringement case

“Reading the claims of the ‘961 patent, the Federal Circuit noted that the claim language did not require the claimed reflective layers to be epitaxial.” ...
Dickinson Wright: A 3-part series of Key Takeaways From Claim Examples In The 2024 AI Patent Eligibility Guideline
Intelectual Property (IP)

Dickinson Wright: A 3-part series of Key Takeaways From Claim Examples In The 2024 AI Patent Eligibility Guideline

Part 1021001010On 17 July 2024, the U.S. Patent and Trademark Office released a new guidance on subject matters eligibility entitled “The 2024 Patent Subject Matter ...
A&O Shearman
Intelectual Property (IP)

A&O Shearman

NEC v TCL, CoA Luxemburg, July 29, 2024 (UPC_CoA_69/2024 & UPC_CoA_70/2024) Daedalus v Xiaomi and MediaTek, CoA Luxemburg, August 5, 2024 (UPC_CoA_183/2024) One of the ...
NPEs Are Not Required to Mark Their Products Under the Statute – And That Should Apply to Settlement Licensees of an NPE
Intelectual Property (IP)

NPEs Are Not Required to Mark Their Products Under the Statute – And That Should Apply to Settlement Licensees of an NPE

With proper pleading, the risks of dismissal or a limitation on damages can be mitigated.” However, with proper pleading, the risks of dismissal or a ...